T2 Biosystems, Inc. financial data

Symbol
TTOO on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
101 Hartwell Avenue, Lexington, MA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 40.1 % -37%
Quick Ratio 11.7 % -2.35%
Debt-to-equity -219 % -8.7%
Return On Equity 206 % +50%
Return On Assets -173 % -27.9%
Operating Margin -543 % -19.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 21M shares +420%
Common Stock, Shares, Outstanding 18.8M shares +379%
Entity Public Float 17.1M USD -44.7%
Common Stock, Value, Issued 18K USD +350%
Weighted Average Number of Shares Outstanding, Basic 17.9M shares +300%
Weighted Average Number of Shares Outstanding, Diluted 17.9M shares +300%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 7.68M USD -30.2%
Research and Development Expense 12.9M USD -17.4%
Costs and Expenses 49.3M USD -18.9%
Operating Income (Loss) -41.7M USD +16.5%
Nonoperating Income (Expense) -1.3M USD -4579%
Net Income (Loss) Attributable to Parent -43M USD +13.8%
Earnings Per Share, Basic 120 USD/shares +83.5%
Earnings Per Share, Diluted 120 USD/shares +83.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 2.08M USD -91.4%
Marketable Securities, Current 0 USD
Accounts Receivable, after Allowance for Credit Loss, Current 2.03M USD +78.5%
Inventory, Net 3.83M USD -10.7%
Assets, Current 9.79M USD -70.2%
Property, Plant and Equipment, Net 1.48M USD -27.7%
Operating Lease, Right-of-Use Asset 6.27M USD -19.1%
Other Assets, Noncurrent 1K USD -98%
Assets 18.1M USD -58.2%
Accounts Payable, Current 4.21M USD +287%
Employee-related Liabilities, Current 3.41M USD +5.64%
Accrued Liabilities, Current 4.63M USD -6.6%
Contract with Customer, Liability, Current 233K USD -15.6%
Liabilities, Current 24.4M USD -55.9%
Contract with Customer, Liability, Noncurrent 59K USD +47.5%
Operating Lease, Liability, Noncurrent 5.3M USD -24.6%
Other Liabilities, Noncurrent 4.79M USD +12.6%
Liabilities 29.8M USD -52.3%
Accumulated Other Comprehensive Income (Loss), Net of Tax -11K USD -169%
Retained Earnings (Accumulated Deficit) -617M USD -7.48%
Stockholders' Equity Attributable to Parent -11.7M USD +39.1%
Liabilities and Equity 18.1M USD -58.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -11.7M USD +9.71%
Net Cash Provided by (Used in) Financing Activities 2.2M USD -81.4%
Net Cash Provided by (Used in) Investing Activities -120K USD -314%
Common Stock, Shares Authorized 400M shares 0%
Common Stock, Shares, Issued 18.8M shares +379%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -9.48M USD -682%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 2.6M USD
Interest Paid, Excluding Capitalized Interest, Operating Activities 839K USD -16.8%
Deferred Tax Assets, Valuation Allowance 87.2M USD -0.69%
Deferred Tax Assets, Gross 89.4M USD -1.26%
Operating Lease, Liability 8.21M USD -14.1%
Payments to Acquire Property, Plant, and Equipment 120K USD +314%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -45.6M USD +28.1%
Lessee, Operating Lease, Liability, to be Paid 10.7M USD -18.4%
Property, Plant and Equipment, Gross 16.5M USD -2.51%
Operating Lease, Liability, Current 1.72M USD +11.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.33M USD -6.27%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.49M USD +3.5%
Operating Lease, Weighted Average Discount Rate, Percent 0.12 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2.46M USD -30%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.89M USD -18.8%
Deferred Tax Assets, Operating Loss Carryforwards 72.1M USD -0.29%
Preferred Stock, Shares Issued 0 shares -100%
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.95M USD +3.01%
Preferred Stock, Shares Outstanding 0 shares -100%
Depreciation, Depletion and Amortization 64K USD -75%
Deferred Tax Assets, Net of Valuation Allowance 2.12M USD -20.1%
Share-based Payment Arrangement, Expense 2.8M USD -39.4%
Interest Expense 5.71M USD -22.2%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%